amlodipine and lu 208075

amlodipine has been researched along with lu 208075 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Higa, A; Hoshi, H; Imai, JI; Ito, E; Morisawa, G; Takagi, M; Watanabe, S; Yanagisawa, Y1

Reviews

1 review(s) available for amlodipine and lu 208075

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for amlodipine and lu 208075

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
    The Journal of toxicological sciences, 2017, Volume: 42, Issue:6

    Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression Profiling; Gene Expression Regulation; Humans; Induced Pluripotent Stem Cells; Linagliptin; Long QT Syndrome; Myocytes, Cardiac; Naphthalenes; Phenylpropionates; Piperazines; Prasugrel Hydrochloride; Pyridazines; Sumatriptan; Tetrazoles; Transcriptome; Up-Regulation

2017